{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "28", "@year": "2021", "@timestamp": "2021-04-28T10:17:53.000053-04:00", "@month": "04"}, "ait:date-sort": {"@day": "01", "@year": "2016", "@month": "08"}}, "xocs:meta": {"xocs:funding-list": {"@pui-match": "primary", "@has-funding-info": "1", "xocs:funding": [{"xocs:funding-agency-matched-string": "Kirby Institute for Infection and Immunity in Society"}, {"xocs:funding-agency-matched-string": "National Health Security Office"}], "xocs:funding-addon-generated-timestamp": "2022-11-16T10:57:33.705998Z", "xocs:funding-text": "This trial was supported by grants from the National Health Security Office and Kirby Institute for Infection and Immunity in Society. The antiretrovirals and some laboratory monitoring were provided by the National Health Security Office. We are grateful to the patients for their participation in this study. We thank the LASA data safety monitoring board and the LASA study team for their dedication to this study.", "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "Thailand", "address-part": "Pathum Wan", "@afid": "60031780", "@country": "tha", "city": "Bangkok", "organization": [{"$": "HIV Netherlands Australia Thailand Research Collaboration"}, {"$": "The Thai Red Cross AIDS Research Centre"}], "affiliation-id": [{"@afid": "60031780"}, {"@afid": "60016965"}]}, "author": [{"ce:given-name": "Torsak", "preferred-name": {"ce:given-name": "Torsak", "ce:initials": "T.", "ce:surname": "Bunupuradah", "ce:indexed-name": "Bunupuradah T."}, "@seq": "1", "ce:initials": "T.", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Bunupuradah", "@auid": "15836773400", "ce:indexed-name": "Bunupuradah T."}, {"ce:given-name": "Anchalee", "preferred-name": {"ce:given-name": "Anchalee", "ce:initials": "A.", "ce:surname": "Avihingsanon", "ce:indexed-name": "Avihingsanon A."}, "@seq": "3", "ce:initials": "A.", "@date-locked": "2018-07-27T21:17:03.882", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Avihingsanon", "@auid": "57196347321", "ce:indexed-name": "Avihingsanon A."}, {"ce:given-name": "Praphan", "preferred-name": {"ce:given-name": "Praphan", "ce:initials": "P.", "ce:surname": "Phanuphak", "ce:indexed-name": "Phanuphak P."}, "@seq": "18", "ce:initials": "P.", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Phanuphak", "@auid": "7004982661", "ce:indexed-name": "Phanuphak P."}, {"ce:given-name": "Tanakorn", "preferred-name": {"ce:given-name": "Tanakorn", "ce:initials": "T.", "ce:surname": "Apornpong", "ce:indexed-name": "Apornpong T."}, "@seq": "20", "ce:initials": "T.", "@_fa": "true", "@type": "auth", "ce:degrees": "MSc", "ce:surname": "Apornpong", "@auid": "36597857000", "ce:indexed-name": "Apornpong T."}, {"ce:given-name": "Stephen J", "preferred-name": {"ce:given-name": "Stephen J.", "ce:initials": "S.J.", "ce:surname": "Kerr", "ce:indexed-name": "Kerr S.J."}, "@seq": "21", "ce:initials": "S.J.", "@_fa": "true", "@type": "auth", "ce:degrees": "PhD", "ce:surname": "Kerr", "@auid": "7102711578", "ce:indexed-name": "Kerr S.J."}, {"ce:given-name": "Kiat", "preferred-name": {"ce:given-name": "Kiat", "ce:initials": "K.", "ce:surname": "Ruxrungtham", "ce:indexed-name": "Ruxrungtham K."}, "@seq": "23", "ce:initials": "K.", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Ruxrungtham", "@auid": "7004208798", "ce:indexed-name": "Ruxrungtham K."}]}, {"affiliation": {"country": "Thailand", "@afid": "60015887", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Faculty of Medicine Ramathibodi Hospital"}, {"$": "Mahidol University"}], "affiliation-id": [{"@afid": "60015887"}, {"@afid": "60012718"}]}, "author": [{"ce:given-name": "Sasisopin", "preferred-name": {"ce:given-name": "Sasisopin", "ce:initials": "S.", "ce:surname": "Kiertiburanakul", "ce:indexed-name": "Kiertiburanakul S."}, "@seq": "2", "ce:initials": "S.", "@date-locked": "2017-11-17T10:20:35.761", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Kiertiburanakul", "@auid": "6506539792", "ce:indexed-name": "Kiertiburanakul S."}]}, {"affiliation": {"country": "Thailand", "@afid": "60017165", "@country": "tha", "city": "Khon Kaen", "organization": {"$": "Khon Kaen University"}, "affiliation-id": {"@afid": "60017165"}}, "author": [{"ce:given-name": "Ploenchan", "preferred-name": {"ce:given-name": "Ploenchan", "ce:initials": "P.", "ce:surname": "Chetchotisakd", "ce:indexed-name": "Chetchotisakd P."}, "@seq": "4", "ce:initials": "P.", "@date-locked": "2017-09-19T07:26:34.619", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Chetchotisakd", "@auid": "56992885200", "ce:indexed-name": "Chetchotisakd P."}]}, {"affiliation": {"country": "Thailand", "@afid": "60028340", "@country": "tha", "city": "Chanthaburi", "organization": [{"$": "Prapokklao Hospital"}, {"$": "Amphur Muang"}], "affiliation-id": {"@afid": "60028340"}}, "author": [{"ce:given-name": "Malee", "preferred-name": {"ce:given-name": "Malee", "ce:initials": "M.", "ce:surname": "Techapornroong", "ce:indexed-name": "Techapornroong M."}, "@seq": "5", "ce:initials": "M.", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Techapornroong", "@auid": "22037090700", "ce:indexed-name": "Techapornroong M."}]}, {"affiliation": {"country": "Thailand", "@afid": "60012921", "@country": "tha", "city": "Khon Kaen", "organization": [{"$": "Khon Kaen Hospital"}, {"$": "Mueang Khon Kaen"}], "affiliation-id": {"@afid": "60012921"}}, "author": [{"ce:given-name": "Niramon", "preferred-name": {"ce:given-name": "Niramon", "ce:initials": "N.", "ce:surname": "Leerattanapetch", "ce:indexed-name": "Leerattanapetch N."}, "@seq": "6", "ce:initials": "N.", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Leerattanapetch", "@auid": "57189350431", "ce:indexed-name": "Leerattanapetch N."}]}, {"affiliation": {"country": "Thailand", "@afid": "102066915", "@country": "tha", "city": "Chiang Rai", "organization": {"$": "Chiangrai Prachanukroh Hospital"}, "affiliation-id": {"@afid": "102066915"}}, "author": [{"ce:given-name": "Pacharee", "preferred-name": {"ce:given-name": "Pacharee", "ce:initials": "P.", "ce:surname": "Kantipong", "ce:indexed-name": "Kantipong P."}, "@seq": "7", "ce:initials": "P.", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Kantipong", "@auid": "6603580797", "ce:indexed-name": "Kantipong P."}]}, {"affiliation": {"country": "Thailand", "@afid": "60029201", "@country": "tha", "city": "Chonburi", "organization": [{"$": "Chonburi Hospital"}, {"$": "Baan Suan Muang"}], "affiliation-id": {"@afid": "60029201"}}, "author": [{"ce:given-name": "Chureeratana", "preferred-name": {"ce:given-name": "Chureeratana", "ce:initials": "C.", "ce:surname": "Bowonwatanuwong", "ce:indexed-name": "Bowonwatanuwong C."}, "@seq": "8", "ce:initials": "C.", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Bowonwatanuwong", "@auid": "19833745200", "ce:indexed-name": "Bowonwatanuwong C."}]}, {"affiliation": {"country": "Thailand", "@afid": "101867798", "@country": "tha", "city": "Rayong", "organization": [{"$": "Rayong Hospital"}, {"$": "Mueang Rayong"}], "affiliation-id": {"@afid": "101867798"}}, "author": [{"ce:given-name": "Sukit", "preferred-name": {"ce:given-name": "Sukit", "ce:initials": "S.", "ce:surname": "Banchongkit", "ce:indexed-name": "Banchongkit S."}, "@seq": "9", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Banchongkit", "@auid": "54934454300", "ce:indexed-name": "Banchongkit S."}]}, {"affiliation": {"country": "Thailand", "@afid": "107077094", "@country": "tha", "city": "Chiang Mai", "organization": [{"$": "Sanpatong Hospital"}, {"$": "San Pa Tong"}], "affiliation-id": {"@afid": "107077094"}}, "author": [{"ce:given-name": "Virat", "preferred-name": {"ce:given-name": "Virat", "ce:initials": "V.", "ce:surname": "Klinbuayaem", "ce:indexed-name": "Klinbuayaem V."}, "@seq": "10", "ce:initials": "V.", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Klinbuayaem", "@auid": "26636470600", "ce:indexed-name": "Klinbuayaem V."}]}, {"affiliation": {"country": "Thailand", "@afid": "100840713", "@country": "tha", "city": "Nonthaburi", "organization": {"$": "Pranangklao Hospital"}, "affiliation-id": {"@afid": "100840713"}}, "author": [{"ce:given-name": "Sripetcharat", "preferred-name": {"ce:given-name": "Sripetcharat", "ce:initials": "S.", "ce:surname": "Mekviwattanawong", "ce:indexed-name": "Mekviwattanawong S."}, "@seq": "11", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Mekviwattanawong", "@auid": "53870491900", "ce:indexed-name": "Mekviwattanawong S."}]}, {"affiliation": {"country": "Thailand", "@afid": "123656911", "@country": "tha", "city": "Nakhon Phatom", "organization": [{"$": "Nakhon Phatom Hospital"}, {"$": "Mueang Nakhon Pathom"}], "affiliation-id": {"@afid": "123656911"}}, "author": [{"ce:given-name": "Sireethorn", "preferred-name": {"ce:given-name": "Sireethorn", "ce:initials": "S.", "ce:surname": "Nimitvilai", "ce:indexed-name": "Nimitvilai S."}, "@seq": "12", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Nimitvilai", "@auid": "57212277075", "ce:indexed-name": "Nimitvilai S."}]}, {"affiliation": {"country": "Thailand", "@afid": "60014909", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Taksin Hospital"}, {"$": "Khlong San"}], "affiliation-id": {"@afid": "60014909"}}, "author": [{"ce:given-name": "Supunnee", "preferred-name": {"ce:given-name": "Supunnee", "ce:initials": "S.", "ce:surname": "Jirajariyavej", "ce:indexed-name": "Jirajariyavej S."}, "@seq": "13", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Jirajariyavej", "@auid": "24764685100", "ce:indexed-name": "Jirajariyavej S."}]}, {"affiliation": {"country": "Thailand", "@afid": "60021173", "@country": "tha", "city": "Nonthaburi", "organization": [{"$": "Bamrasnaradura Infectious Disease Institute"}, {"$": "Mueang Nonthaburi"}], "affiliation-id": {"@afid": "60021173"}}, "author": [{"ce:given-name": "Wisit", "preferred-name": {"ce:given-name": "Wisit", "ce:initials": "W.", "ce:surname": "Prasithsirikul", "ce:indexed-name": "Prasithsirikul W."}, "@seq": "14", "ce:initials": "W.", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Prasithsirikul", "@auid": "14032276000", "ce:indexed-name": "Prasithsirikul W."}]}, {"affiliation": {"country": "Thailand", "address-part": "Dusit", "@afid": "60033133", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Faculty of Medicine"}, {"$": "Vajira Hospital"}, {"$": "University of Bangkok Metropolitan Administration"}, {"$": "Wachira Phayaban"}], "affiliation-id": [{"@afid": "60033133"}, {"@afid": "60020352"}]}, "author": [{"ce:given-name": "Warangkana", "preferred-name": {"ce:given-name": "Warangkana", "ce:initials": "W.", "ce:surname": "Munsakul", "ce:indexed-name": "Munsakul W."}, "@seq": "15", "ce:initials": "W.", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Munsakul", "@auid": "35308921700", "ce:indexed-name": "Munsakul W."}]}, {"affiliation": {"country": "Thailand", "@afid": "60092132", "@country": "tha", "city": "Nonthaburi", "organization": {"$": "The National Health Security Office"}, "affiliation-id": {"@afid": "60092132"}}, "author": [{"ce:given-name": "Sorakij", "preferred-name": {"ce:given-name": "Sorakij", "ce:initials": "S.", "ce:surname": "Bhakeecheep", "ce:indexed-name": "Bhakeecheep S."}, "@seq": "16", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Bhakeecheep", "@auid": "13614152900", "ce:indexed-name": "Bhakeecheep S."}, {"ce:given-name": "Suchada", "preferred-name": {"ce:given-name": "Suchada", "ce:initials": "S.", "ce:surname": "Chaivooth", "ce:indexed-name": "Chaivooth S."}, "@seq": "17", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Chaivooth", "@auid": "57189031115", "ce:indexed-name": "Chaivooth S."}]}, {"affiliation": {"country": "Australia", "@afid": "60026655", "@country": "aus", "city": "Sydney", "organization": [{"$": "Kirby Institute for Infection and Immunity in Society"}, {"$": "University of New South Wales"}], "affiliation-id": [{"@afid": "60026655"}, {"@afid": "60028333"}], "state": "NSW"}, "author": [{"ce:given-name": "David A", "preferred-name": {"ce:given-name": "David A.", "ce:initials": "D.A.", "ce:surname": "Cooper", "ce:indexed-name": "Cooper D.A."}, "@seq": "19", "ce:initials": "D.A.", "@_fa": "true", "@type": "auth", "ce:degrees": "DSc", "ce:surname": "Cooper", "@auid": "36078697200", "ce:indexed-name": "Cooper D.A."}, {"ce:given-name": "Stephen J", "preferred-name": {"ce:given-name": "Stephen J.", "ce:initials": "S.J.", "ce:surname": "Kerr", "ce:indexed-name": "Kerr S.J."}, "@seq": "21", "ce:initials": "S.J.", "@_fa": "true", "@type": "auth", "ce:degrees": "PhD", "ce:surname": "Kerr", "@auid": "7102711578", "ce:indexed-name": "Kerr S.J."}, {"ce:given-name": "Sean", "preferred-name": {"ce:given-name": "Sean", "ce:initials": "S.", "ce:surname": "Emery", "ce:indexed-name": "Emery S."}, "@seq": "22", "ce:initials": "S.", "@date-locked": "2019-12-13T06:53:58.909", "@_fa": "true", "@type": "auth", "ce:degrees": "PhD", "ce:surname": "Emery", "@auid": "57188785246", "ce:indexed-name": "Emery S."}]}, {"affiliation": {"country": "Netherlands", "@afid": "60002483", "@country": "nld", "city": "Amsterdam", "organization": [{"$": "Department of Global Health"}, {"$": "Academic Medical Center"}, {"$": "University of Amsterdam"}, {"$": "Amsterdam Institute for Global Health and Development"}], "affiliation-id": [{"@afid": "60002483", "@dptid": "103175885"}, {"@afid": "60138854"}, {"@afid": "60001157"}], "@dptid": "103175885"}, "author": [{"ce:given-name": "Stephen J", "preferred-name": {"ce:given-name": "Stephen J.", "ce:initials": "S.J.", "ce:surname": "Kerr", "ce:indexed-name": "Kerr S.J."}, "@seq": "21", "ce:initials": "S.J.", "@_fa": "true", "@type": "auth", "ce:degrees": "PhD", "ce:surname": "Kerr", "@auid": "7102711578", "ce:indexed-name": "Kerr S.J."}]}, {"affiliation": {"country": "Thailand", "address-part": "Pathum Wan", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Medicine"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "113019942"}, "@dptid": "113019942"}, "author": [{"ce:given-name": "Kiat", "preferred-name": {"ce:given-name": "Kiat", "ce:initials": "K.", "ce:surname": "Ruxrungtham", "ce:indexed-name": "Ruxrungtham K."}, "@seq": "23", "ce:initials": "K.", "@_fa": "true", "@type": "auth", "ce:degrees": "MD", "ce:surname": "Ruxrungtham", "@auid": "7004208798", "ce:indexed-name": "Ruxrungtham K."}]}, {"collaboration": {"@seq": "24", "ce:text": "LASA Study Group", "ce:indexed-name": "LASA Study Group"}}], "citation-title": "Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial", "abstracts": "\u00a9 2016 Elsevier LtdBackground Thai patients with HIV have higher exposure to HIV protease inhibitors than do white people and dose reduction might be possible. We compared the efficacy of low-dose with standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai patients with HIV. Methods In this randomised, open-label, non-inferiority trial, we recruited patients aged 18 years or older who were receiving ritonavir-boosted protease-inhibitor-based antiretroviral therapy (ART) with HIV plasma viral loads of less than 50 copies per mL, an alanine aminotransferase concentration of less than 200 IU/L, and a creatinine clearance of at least 60 mL/min from 14 hospitals in Thailand. We excluded patients who had active AIDS-defining disease or opportunistic infections, had a history of an HIV viral load of 1000 copies per mL or more after 24 weeks of any ritonavir-boosted protease-inhibitor-based ART, used concomitant medications that could interact with the study drugs, were pregnant or lactating, had illnesses that might change the effect of the study drugs, or had a history of sensitivity to the study drugs. A biostatistician at the study coordinating centre randomly allocated patients (1:1) to switch the protease inhibitor for oral atazanavir 200 mg and ritonavir 100 mg or for atazanavir 300 mg and ritonavir 100 mg once daily, both with two nucleoside or nucleotide reverse transcriptase inhibitors at recommended doses. Randomisation was done with a minimisation schedule, stratified by recruiting centre, use of tenofovir, and use of indinavir as a component of the preswitch regimen. The primary endpoint was the proportion of patients with viral loads of less than 200 copies per mL at week 48, and we followed up patients every 12 weeks. Treatments were open label, the non-inferiority margin was \u221210%, and all patients who received at least one dose of study medication were analysed. This trial is registered with ClinicalTrials.gov, number NCT01159223. Findings Between July 6, 2011, and Dec 23, 2013, we randomly assigned 559 patients: 279 to receive atazanavir 200 mg and ritonavir 100 mg (low dose) and 280 to atazanavir 300 mg and ritonavir 100 mg (standard dose). At week 48, 265 (97\u00b71%) of 273 in the low-dose group and 267 (96\u00b74%) of 277 in the standard-dose group had viral loads of less than 200 copies per mL (difference 0\u00b768; 95% CI \u22122\u00b729 to 3\u00b765). Seven (3%) of 273 in the low-dose group and 21 (8%) of 277 in the standard-dose group discontinued their assigned treatment (p=0\u00b701). 46 (17%) of 273 participants in the low-dose group and 97 (35%) of 277 in the standard-dose group had total bilirubin grade 3 or higher toxicity (\u22653\u00b712 mg/dL; p<0\u00b70001). Interpretation A switch to low-dose atazanavir should be recommended for Thai patients with well controlled HIV viraemia while on regimens based on boosted protease inhibitors. Funding The National Health Security Office and Kirby Institute for Infection and Immunity in Society.", "correspondence": {"affiliation": {"country": "Thailand", "address-part": "Pathum Wan", "postal-code": "10330", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Medicine"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}]}, "person": {"ce:given-name": "Kiat", "ce:initials": "K.", "ce:degrees": "MD", "ce:surname": "Ruxrungtham", "ce:indexed-name": "Ruxrungtham K."}}, "citation-info": {"citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"sourcetitle-abbrev": "Lancet HIV", "website": {"ce:e-address": {"$": "http://www.journals.elsevier.com/the-lancet-hiv/", "@type": "email"}}, "@country": "gbr", "translated-sourcetitle": {"@xml:lang": "eng"}, "issn": {"$": "23523018", "@type": "electronic"}, "volisspag": {"voliss": {"@volume": "3", "@issue": "8"}, "pagerange": {"@first": "e343", "@last": "e350"}}, "@type": "j", "publicationyear": {"@first": "2016"}, "publisher": {"publishername": "Elsevier Ltd"}, "sourcetitle": "The Lancet HIV", "@srcid": "21100369870", "publicationdate": {"month": "08", "year": "2016", "date-text": {"@xfab-added": "true", "$": "1 August 2016"}, "day": "01"}}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "ASJC", "classification": [{"$": "2713"}, {"$": "2403"}, {"$": "2725"}, {"$": "2406"}]}, {"@type": "SUBJABBR", "classification": [{"$": "MEDI"}, {"$": "IMMU"}]}]}, "chemicalgroup": {"chemicals": [{"@source": "esbd", "chemical": [{"cas-registry-number": "198904-31-3", "chemical-name": "atazanavir"}, {"cas-registry-number": "69655-05-6", "chemical-name": "didanosine"}, {"cas-registry-number": [{"$": "150378-17-9"}, {"$": "157810-81-6"}, {"$": "180683-37-8"}], "chemical-name": "indinavir"}, {"cas-registry-number": [{"$": "134678-17-4"}, {"$": "134680-32-3"}], "chemical-name": "lamivudine"}, {"cas-registry-number": "192725-17-0", "chemical-name": "lopinavir"}, {"cas-registry-number": [{"$": "159989-64-7"}, {"$": "159989-65-8"}], "chemical-name": "nelfinavir"}, {"cas-registry-number": "155213-67-5", "chemical-name": "ritonavir"}, {"cas-registry-number": [{"$": "127779-20-8"}, {"$": "149845-06-7"}], "chemical-name": "saquinavir"}, {"cas-registry-number": "3056-17-5", "chemical-name": "stavudine"}, {"cas-registry-number": [{"$": "147127-19-3"}, {"$": "147127-20-6"}], "chemical-name": "tenofovir"}, {"cas-registry-number": "30516-87-1", "chemical-name": "zidovudine"}]}, {"@source": "nlm", "chemical": [{"chemical-name": "Atazanavir Sulfate"}, {"chemical-name": "HIV Protease Inhibitors"}, {"chemical-name": "Ritonavir"}]}]}}}, "item-info": {"copyright": {"$": "Copyright 2019 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "external-source": "MEDLINE", "dbcollection": [{"$": "EMBASE"}, {"$": "MEDL"}, {"$": "NURSNG"}, {"$": "REAXYSCAR"}, {"$": "SCOPUS"}, {"$": "SNEMB"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "19", "@year": "2019", "@timestamp": "BST 11:53:39", "@month": "12"}}, "itemidlist": {"itemid": [{"$": "610471336", "@idtype": "PUI"}, {"$": "650695160", "@idtype": "CAR-ID"}, {"$": "20160389688", "@idtype": "EMBASE"}, {"$": "27470026", "@idtype": "MEDL"}, {"$": "2016181916", "@idtype": "NURSNG"}, {"$": "20161228609", "@idtype": "REAXYSCAR"}, {"$": "20193706362", "@idtype": "SCOPUS"}, {"$": "2016057448", "@idtype": "SNEMB"}, {"$": "84969667316", "@idtype": "SCP"}, {"$": "84969667316", "@idtype": "SGR"}, {"$": "616752765", "@idtype": "PUIsecondary"}], "ce:pii": "S2352301816300108", "ce:doi": "10.1016/S2352-3018(16)30010-8"}}, "tail": {"bibliography": {"@refcount": "22", "reference": [{"ref-fulltext": "1 WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach, 2013, World Health Organization, Geneva.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "refd-itemidlist": {"itemid": {"$": "84882279538", "@idtype": "SGR"}}, "ref-text": "World Health Organization Geneva", "ref-sourcetitle": "Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach"}}, {"ref-fulltext": "2 Molina, JM, Andrade-Villanueva, J, Echevarria, J, et al., for the CASTLE Study Team. Once-daily atazanavir/ritonavir compared with twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 96-week efficacy and safety results of the CASTLE study. J Acquir Immun Defic Syndr 53 (2010), 323\u2013332.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Once-daily atazanavir/ritonavir compared with twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 96-week efficacy and safety results of the CASTLE study"}, "refd-itemidlist": {"itemid": {"$": "77649201378", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "53"}, "pagerange": {"@first": "323", "@last": "332"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.M.", "@_fa": "true", "ce:surname": "Molina", "ce:indexed-name": "Molina J.M."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Andrade-Villanueva", "ce:indexed-name": "Andrade-Villanueva J."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Echevarria", "ce:indexed-name": "Echevarria J."}], "collaboration": {"@seq": "1", "ce:text": "for the CASTLE Study Team", "ce:indexed-name": "for the CASTLE Study Team"}, "et-al": null}, "ref-sourcetitle": "J Acquir Immun Defic Syndr"}}, {"ref-fulltext": "3 Soriano, V, Garcia-Gasco, P, Vispo, E, et al. Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial. J Antimicrob Chemother 61 (2008), 200\u2013205.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial"}, "refd-itemidlist": {"itemid": {"$": "37549038211", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "61"}, "pagerange": {"@first": "200", "@last": "205"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Soriano", "ce:indexed-name": "Soriano V."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Garcia-Gasco", "ce:indexed-name": "Garcia-Gasco P."}, {"@seq": "3", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Vispo", "ce:indexed-name": "Vispo E."}], "et-al": null}, "ref-sourcetitle": "J Antimicrob Chemother"}}, {"ref-fulltext": "4 Mallolas, J, Podzamczer, D, Milinkovic, A, et al., for the ATAZIP Study Group. Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study. J Acquir Immun Defic Syndr 51 (2009), 29\u201336 1999.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study"}, "refd-itemidlist": {"itemid": {"$": "67049130751", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "51"}, "pagerange": {"@first": "29", "@last": "36"}}, "ref-text": "1999", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Mallolas", "ce:indexed-name": "Mallolas J."}, {"@seq": "2", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Podzamczer", "ce:indexed-name": "Podzamczer D."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Milinkovic", "ce:indexed-name": "Milinkovic A."}], "collaboration": {"@seq": "1", "ce:text": "for the ATAZIP Study Group", "ce:indexed-name": "for the ATAZIP Study Group"}, "et-al": null}, "ref-sourcetitle": "J Acquir Immun Defic Syndr"}}, {"ref-fulltext": "5 Avihingsanon, A, Manosuthi, W, Kantipong, P, et al. Pharmacokinetics and 48-week efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampin. Antivir Ther 13 (2008), 529\u2013536.", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Pharmacokinetics and 48-week efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampin"}, "refd-itemidlist": {"itemid": {"$": "47649116684", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "13"}, "pagerange": {"@first": "529", "@last": "536"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Avihingsanon", "ce:indexed-name": "Avihingsanon A."}, {"@seq": "2", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Manosuthi", "ce:indexed-name": "Manosuthi W."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Kantipong", "ce:indexed-name": "Kantipong P."}], "et-al": null}, "ref-sourcetitle": "Antivir Ther"}}, {"ref-fulltext": "6 Boyd, M, Mootsikapun, P, Burger, D, et al. Pharmacokinetics of reduced-dose indinavir/ritonavir 400/100 mg twice daily in HIV-1-infected Thai patients. Antivir Ther 10 (2005), 301\u2013307.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Pharmacokinetics of reduced-dose indinavir/ritonavir 400/100 mg twice daily in HIV-1-infected Thai patients"}, "refd-itemidlist": {"itemid": {"$": "22844448412", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "10"}, "pagerange": {"@first": "301", "@last": "307"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Boyd", "ce:indexed-name": "Boyd M."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Mootsikapun", "ce:indexed-name": "Mootsikapun P."}, {"@seq": "3", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Burger", "ce:indexed-name": "Burger D."}], "et-al": null}, "ref-sourcetitle": "Antivir Ther"}}, {"ref-fulltext": "7 Autar, RS, Boffito, M, Hassink, E, et al. Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patients. J Antimicrob Chemother 56 (2005), 908\u2013913.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patients"}, "refd-itemidlist": {"itemid": {"$": "27744594298", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "56"}, "pagerange": {"@first": "908", "@last": "913"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.S.", "@_fa": "true", "ce:surname": "Autar", "ce:indexed-name": "Autar R.S."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Boffito", "ce:indexed-name": "Boffito M."}, {"@seq": "3", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Hassink", "ce:indexed-name": "Hassink E."}], "et-al": null}, "ref-sourcetitle": "J Antimicrob Chemother"}}, {"ref-fulltext": "8 van der Lugt, J, Autar, RS, Ubolyam, S, et al., for the HIV-NAT 019 Study Team. Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adults. J Antimicrob Chemother 61 (2008), 1145\u20131153.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adults"}, "refd-itemidlist": {"itemid": {"$": "42149113999", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "61"}, "pagerange": {"@first": "1145", "@last": "1153"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "van der Lugt", "ce:indexed-name": "van der Lugt J."}, {"@seq": "2", "ce:initials": "R.S.", "@_fa": "true", "ce:surname": "Autar", "ce:indexed-name": "Autar R.S."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Ubolyam", "ce:indexed-name": "Ubolyam S."}], "collaboration": {"@seq": "1", "ce:text": "for the HIV-NAT 019 Study Team", "ce:indexed-name": "for the HIV-NAT 019 Study Team"}, "et-al": null}, "ref-sourcetitle": "J Antimicrob Chemother"}}, {"ref-fulltext": "9 Avihingsanon, A, van der Lugt, J, Kerr, SJ, et al. A low dose of ritonavir-boosted atazanavir provides adequate pharmacokinetic parameters in HIV-1-infected Thai adults. Clin Pharmacol Ther 85 (2009), 402\u2013408.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "A low dose of ritonavir-boosted atazanavir provides adequate pharmacokinetic parameters in HIV-1-infected Thai adults"}, "refd-itemidlist": {"itemid": {"$": "62649107112", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "85"}, "pagerange": {"@first": "402", "@last": "408"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Avihingsanon", "ce:indexed-name": "Avihingsanon A."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "van der Lugt", "ce:indexed-name": "van der Lugt J."}, {"@seq": "3", "ce:initials": "S.J.", "@_fa": "true", "ce:surname": "Kerr", "ce:indexed-name": "Kerr S.J."}], "et-al": null}, "ref-sourcetitle": "Clin Pharmacol Ther"}}, {"ref-fulltext": "10 Gorowara, M, Burger, D, Hill, A, Ruxrungtham, K, Pharmacokinetics of low-dose protease inhibitors and efavirenz in low- and middle-income countries. Curr Opin HIV AIDS 5 (2010), 90\u201396.", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Pharmacokinetics of low-dose protease inhibitors and efavirenz in low- and middle-income countries"}, "refd-itemidlist": {"itemid": {"$": "74349123323", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "5"}, "pagerange": {"@first": "90", "@last": "96"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Gorowara", "ce:indexed-name": "Gorowara M."}, {"@seq": "2", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Burger", "ce:indexed-name": "Burger D."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Hill", "ce:indexed-name": "Hill A."}, {"@seq": "4", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Ruxrungtham", "ce:indexed-name": "Ruxrungtham K."}]}, "ref-sourcetitle": "Curr Opin HIV AIDS"}}, {"ref-fulltext": "11 Chetchotisakd, P, Anunnatsiri, S, Low-dose, once-daily atazanavir/ritonavir (200/100): an effective treatment for HIV-infected patients in Thailand. J Acquir Immun Defic Syndr 49 (2008), 230\u2013231 1999.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Low-dose, once-daily atazanavir/ritonavir (200/100): an effective treatment for HIV-infected patients in Thailand"}, "refd-itemidlist": {"itemid": {"$": "55249090146", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "49"}, "pagerange": {"@first": "230", "@last": "231"}}, "ref-text": "1999", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Chetchotisakd", "ce:indexed-name": "Chetchotisakd P."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Anunnatsiri", "ce:indexed-name": "Anunnatsiri S."}]}, "ref-sourcetitle": "J Acquir Immun Defic Syndr"}}, {"ref-fulltext": "12 Kerr, SJ, Avihingsanon, A, Putcharoen, O, et al. Assessing adherence in Thai patients taking combination antiretroviral therapy. Int J STD AIDS 23 (2012), 160\u2013165.", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Assessing adherence in Thai patients taking combination antiretroviral therapy"}, "refd-itemidlist": {"itemid": {"$": "84860907905", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "23"}, "pagerange": {"@first": "160", "@last": "165"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.J.", "@_fa": "true", "ce:surname": "Kerr", "ce:indexed-name": "Kerr S.J."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Avihingsanon", "ce:indexed-name": "Avihingsanon A."}, {"@seq": "3", "ce:initials": "O.", "@_fa": "true", "ce:surname": "Putcharoen", "ce:indexed-name": "Putcharoen O."}], "et-al": null}, "ref-sourcetitle": "Int J STD AIDS"}}, {"ref-fulltext": "13 National Institute of Allergy and Infectious Disease. The Division of AIDS table for grading the severity of adult and pediatric adverse events. http://rsc.tech-res.com/Document/safetyandpharmacovigilance/Table_for_Grading_Severity_of_Adult_Pediatric_Adverse_Events.pdf, August, 2009 (accessed Feb 14, 2013).", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-website": {"ce:e-address": {"$": "http://rsc.tech-res.com/Document/safetyandpharmacovigilance/Table_for_Grading_Severity_of_Adult_Pediatric_Adverse_Events.pdf", "@type": "email"}}, "ref-title": {"ref-titletext": "The Division of AIDS table for grading the severity of adult and pediatric adverse events"}, "refd-itemidlist": {"itemid": {"$": "34548307594", "@idtype": "SGR"}}, "ref-text": "(accessed Feb 14, 2013)."}}, {"ref-fulltext": "14 Puls, R, Amin, J, Losso, M, et al. Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial. Lancet 383 (2014), 1474\u20131482.", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial"}, "refd-itemidlist": {"itemid": {"$": "84899620845", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "383"}, "pagerange": {"@first": "1474", "@last": "1482"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Puls", "ce:indexed-name": "Puls R."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Amin", "ce:indexed-name": "Amin J."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Losso", "ce:indexed-name": "Losso M."}], "et-al": null}, "ref-sourcetitle": "Lancet"}}, {"ref-fulltext": "15 Molto, J, Valle, M, Ferrer, E, et al., for the DRV600 Study Group. Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trial. J Antimicrob Chemother 70 (2015), 1139\u20131145.", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trial"}, "refd-itemidlist": {"itemid": {"$": "84926455588", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "70"}, "pagerange": {"@first": "1139", "@last": "1145"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Molto", "ce:indexed-name": "Molto J."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Valle", "ce:indexed-name": "Valle M."}, {"@seq": "3", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Ferrer", "ce:indexed-name": "Ferrer E."}], "collaboration": {"@seq": "1", "ce:text": "for the DRV600 Study Group", "ce:indexed-name": "for the DRV600 Study Group"}, "et-al": null}, "ref-sourcetitle": "J Antimicrob Chemother"}}, {"ref-fulltext": "16 Lennox, JL, Landovitz, RJ, Ribaudo, HJ, et al., for the ACTG A5257 Team. Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial. Ann Intern Med 161 (2014), 461\u2013471.", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial"}, "refd-itemidlist": {"itemid": {"$": "84908086389", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "161"}, "pagerange": {"@first": "461", "@last": "471"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.L.", "@_fa": "true", "ce:surname": "Lennox", "ce:indexed-name": "Lennox J.L."}, {"@seq": "2", "ce:initials": "R.J.", "@_fa": "true", "ce:surname": "Landovitz", "ce:indexed-name": "Landovitz R.J."}, {"@seq": "3", "ce:initials": "H.J.", "@_fa": "true", "ce:surname": "Ribaudo", "ce:indexed-name": "Ribaudo H.J."}], "collaboration": {"@seq": "1", "ce:text": "for the ACTG A5257 Team", "ce:indexed-name": "for the ACTG A5257 Team"}, "et-al": null}, "ref-sourcetitle": "Ann Intern Med"}}, {"ref-fulltext": "17 Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents, 2016, Department of Health and Human Services, Washington, DC.", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "refd-itemidlist": {"itemid": {"$": "84855616052", "@idtype": "SGR"}}, "ref-text": "Department of Health and Human Services Washington, DC", "ref-sourcetitle": "Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents"}}, {"ref-fulltext": "18 Molina, JM, Andrade-Villanueva, J, Echevarria, J, et al., for the CASTLE Study Team. Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study. Lancet 372 (2008), 646\u2013655.", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study"}, "refd-itemidlist": {"itemid": {"$": "49649112490", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "372"}, "pagerange": {"@first": "646", "@last": "655"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.M.", "@_fa": "true", "ce:surname": "Molina", "ce:indexed-name": "Molina J.M."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Andrade-Villanueva", "ce:indexed-name": "Andrade-Villanueva J."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Echevarria", "ce:indexed-name": "Echevarria J."}], "collaboration": {"@seq": "1", "ce:text": "for the CASTLE Study Team", "ce:indexed-name": "for the CASTLE Study Team"}, "et-al": null}, "ref-sourcetitle": "Lancet"}}, {"ref-fulltext": "19 Perez-Molina, JA, Rubio, R, Rivero, A, et al., for the GESIDA 7011 Study Group. Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial. Lancet Infect Dis 15 (2015), 775\u2013784.", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial"}, "refd-itemidlist": {"itemid": {"$": "84937525992", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "15"}, "pagerange": {"@first": "775", "@last": "784"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.A.", "@_fa": "true", "ce:surname": "Perez-Molina", "ce:indexed-name": "Perez-Molina J.A."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Rubio", "ce:indexed-name": "Rubio R."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Rivero", "ce:indexed-name": "Rivero A."}], "collaboration": {"@seq": "1", "ce:text": "for the GESIDA 7011 Study Group", "ce:indexed-name": "for the GESIDA 7011 Study Group"}, "et-al": null}, "ref-sourcetitle": "Lancet Infect Dis"}}, {"ref-fulltext": "20 Squires, KE, Young, B, DeJesus, E, et al., for the ARIES Study Team. Safety and efficacy of a 36-week induction regimen of abacavir/lamivudine and ritonavir-boosted atazanavir in HIV-infected patients. HIV Clin Trials 11 (2010), 69\u201379.", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Safety and efficacy of a 36-week induction regimen of abacavir/lamivudine and ritonavir-boosted atazanavir in HIV-infected patients"}, "refd-itemidlist": {"itemid": {"$": "77953592114", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "11"}, "pagerange": {"@first": "69", "@last": "79"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.E.", "@_fa": "true", "ce:surname": "Squires", "ce:indexed-name": "Squires K.E."}, {"@seq": "2", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Young", "ce:indexed-name": "Young B."}, {"@seq": "3", "ce:initials": "E.", "@_fa": "true", "ce:surname": "DeJesus", "ce:indexed-name": "DeJesus E."}], "collaboration": {"@seq": "1", "ce:text": "for the ARIES Study Team", "ce:indexed-name": "for the ARIES Study Team"}, "et-al": null}, "ref-sourcetitle": "HIV Clin Trials"}}, {"ref-fulltext": "21 Bunupuradah, T, Chetchotisakd, P, Ananworanich, J, et al., for the HIV STAR Study Group. A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: the HIV STAR study. Antivir Ther 17 (2012), 1351\u20131361.", "@id": "21", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: the HIV STAR study"}, "refd-itemidlist": {"itemid": {"$": "84867636454", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "17"}, "pagerange": {"@first": "1351", "@last": "1361"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Bunupuradah", "ce:indexed-name": "Bunupuradah T."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Chetchotisakd", "ce:indexed-name": "Chetchotisakd P."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Ananworanich", "ce:indexed-name": "Ananworanich J."}], "collaboration": {"@seq": "1", "ce:text": "for the HIV STAR Study Group", "ce:indexed-name": "for the HIV STAR Study Group"}, "et-al": null}, "ref-sourcetitle": "Antivir Ther"}}, {"ref-fulltext": "22 Avihingsanon, A, Apornpong, T, Kerr, SJ, et al. Low-dose ritonavir-boosted atazanavir (200/100 mg) maintained a high virological efficacy up to 4 years in treatment-experienced HIV-1 infected adults: a prospective cohort study from Asia. J AIDS Clin Res, 6, 2015, 460.", "@id": "22", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Low-dose ritonavir-boosted atazanavir (200/100 mg) maintained a high virological efficacy up to 4 years in treatment-experienced HIV-1 infected adults: a prospective cohort study from Asia"}, "refd-itemidlist": {"itemid": {"$": "84994880704", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "6"}, "pagerange": {"@first": "460"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Avihingsanon", "ce:indexed-name": "Avihingsanon A."}, {"@seq": "2", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Apornpong", "ce:indexed-name": "Apornpong T."}, {"@seq": "3", "ce:initials": "S.J.", "@_fa": "true", "ce:surname": "Kerr", "ce:indexed-name": "Kerr S.J."}], "et-al": null}, "ref-sourcetitle": "J AIDS Clin Res"}}]}}}}, "affiliation": [{"affiliation-city": "Nontaburi", "@id": "60092132", "affilname": "National Health Security Office", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60092132", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "60033133", "affilname": "Bangkok Metropolitan Administration", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60033133", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "60031780", "affilname": "Thai Red Cross Agency", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780", "affiliation-country": "Thailand"}, {"affiliation-city": null, "@id": "60029201", "affilname": "Chonburi Regional Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029201", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "60028340", "affilname": "Prapokklao Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028340", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, {"affiliation-city": "Kensington", "@id": "60026655", "affilname": "The Kirby Institute", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026655", "affiliation-country": "Australia"}, {"affiliation-city": "Nontaburi", "@id": "60021173", "affilname": "Bamrasnaradura Infectious Disease Institute", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021173", "affiliation-country": "Thailand"}, {"affiliation-city": "Khon Kaen", "@id": "60017165", "affilname": "Khon Kaen University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017165", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "60015887", "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "60014909", "affilname": "Taksin Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014909", "affiliation-country": "Thailand"}, {"affiliation-city": "Khon Kaen", "@id": "60012921", "affilname": "Khon Kaen Regional Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012921", "affiliation-country": "Thailand"}, {"affiliation-city": "Amsterdam", "@id": "60002483", "affilname": "Universiteit van Amsterdam", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002483", "affiliation-country": "Netherlands"}, {"affiliation-city": "Nakhon Pathom", "@id": "123656911", "affilname": "Nakhon Phatom Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/123656911", "affiliation-country": "Thailand"}, {"affiliation-city": "Chaing Mai", "@id": "107077094", "affilname": "Sanpatong Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/107077094", "affiliation-country": "Thailand"}, {"affiliation-city": "Chiang Rai", "@id": "102066915", "affilname": "Chiangrai Prachanukroh Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/102066915", "affiliation-country": "Thailand"}, {"affiliation-city": "Rayong", "@id": "101867798", "affilname": "Rayong Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101867798", "affiliation-country": "Thailand"}, {"affiliation-city": "Nontaburi", "@id": "100840713", "affilname": "Pranangklao Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100840713", "affiliation-country": "Thailand"}], "coredata": {"srctype": "j", "eid": "2-s2.0-84969667316", "dc:description": "Background Thai patients with HIV have higher exposure to HIV protease inhibitors than do white people and dose reduction might be possible. We compared the efficacy of low-dose with standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai patients with HIV. Methods In this randomised, open-label, non-inferiority trial, we recruited patients aged 18 years or older who were receiving ritonavir-boosted protease-inhibitor-based antiretroviral therapy (ART) with HIV plasma viral loads of less than 50 copies per mL, an alanine aminotransferase concentration of less than 200 IU/L, and a creatinine clearance of at least 60 mL/min from 14 hospitals in Thailand. We excluded patients who had active AIDS-defining disease or opportunistic infections, had a history of an HIV viral load of 1000 copies per mL or more after 24 weeks of any ritonavir-boosted protease-inhibitor-based ART, used concomitant medications that could interact with the study drugs, were pregnant or lactating, had illnesses that might change the effect of the study drugs, or had a history of sensitivity to the study drugs. A biostatistician at the study coordinating centre randomly allocated patients (1:1) to switch the protease inhibitor for oral atazanavir 200 mg and ritonavir 100 mg or for atazanavir 300 mg and ritonavir 100 mg once daily, both with two nucleoside or nucleotide reverse transcriptase inhibitors at recommended doses. Randomisation was done with a minimisation schedule, stratified by recruiting centre, use of tenofovir, and use of indinavir as a component of the preswitch regimen. The primary endpoint was the proportion of patients with viral loads of less than 200 copies per mL at week 48, and we followed up patients every 12 weeks. Treatments were open label, the non-inferiority margin was \u221210%, and all patients who received at least one dose of study medication were analysed. This trial is registered with ClinicalTrials.gov, number NCT01159223. Findings Between July 6, 2011, and Dec 23, 2013, we randomly assigned 559 patients: 279 to receive atazanavir 200 mg and ritonavir 100 mg (low dose) and 280 to atazanavir 300 mg and ritonavir 100 mg (standard dose). At week 48, 265 (97\u00b71%) of 273 in the low-dose group and 267 (96\u00b74%) of 277 in the standard-dose group had viral loads of less than 200 copies per mL (difference 0\u00b768; 95% CI \u22122\u00b729 to 3\u00b765). Seven (3%) of 273 in the low-dose group and 21 (8%) of 277 in the standard-dose group discontinued their assigned treatment (p=0\u00b701). 46 (17%) of 273 participants in the low-dose group and 97 (35%) of 277 in the standard-dose group had total bilirubin grade 3 or higher toxicity (\u22653\u00b712 mg/dL; p<0\u00b70001). Interpretation A switch to low-dose atazanavir should be recommended for Thai patients with well controlled HIV viraemia while on regimens based on boosted protease inhibitors. Funding The National Health Security Office and Kirby Institute for Infection and Immunity in Society.", "pubmed-id": "27470026", "prism:coverDate": "2016-08-01", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/84969667316", "dc:creator": {"author": [{"ce:given-name": "Torsak", "preferred-name": {"ce:given-name": "Torsak", "ce:initials": "T.", "ce:surname": "Bunupuradah", "ce:indexed-name": "Bunupuradah T."}, "@seq": "1", "ce:initials": "T.", "@_fa": "true", "affiliation": {"@id": "60031780", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780"}, "ce:degrees": "MD", "ce:surname": "Bunupuradah", "@auid": "15836773400", "author-url": "https://api.elsevier.com/content/author/author_id/15836773400", "ce:indexed-name": "Bunupuradah T."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/84969667316"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84969667316&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84969667316&origin=inward"}], "source-id": "21100369870", "pii": "S2352301816300108", "citedby-count": "25", "prism:volume": "3", "subtype": "ar", "dc:title": "Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial", "openaccess": "0", "prism:issn": "23523018", "publishercopyright": "\u00a9 2016 Elsevier Ltd", "prism:issueIdentifier": "8", "subtypeDescription": "Article", "prism:publicationName": "The Lancet HIV", "prism:pageRange": "e343-e350", "prism:endingPage": "e350", "openaccessFlag": "false", "prism:doi": "10.1016/S2352-3018(16)30010-8", "prism:startingPage": "e343", "dc:identifier": "SCOPUS_ID:84969667316", "dc:publisher": "Elsevier Ltd"}, "idxterms": {"mainterm": [{"$": "Adolescent", "@weight": "b", "@candidate": "n"}, {"$": "Adult", "@weight": "b", "@candidate": "n"}, {"$": "Atazanavir Sulfate", "@weight": "b", "@candidate": "n"}, {"$": "Dose-Response Relationship, Drug", "@weight": "b", "@candidate": "n"}, {"$": "Female", "@weight": "b", "@candidate": "n"}, {"$": "HIV Infections", "@weight": "b", "@candidate": "n"}, {"$": "HIV Protease Inhibitors", "@weight": "b", "@candidate": "n"}, {"$": "HIV-1", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "Male", "@weight": "b", "@candidate": "n"}, {"$": "Pregnancy", "@weight": "b", "@candidate": "n"}, {"$": "Ritonavir", "@weight": "b", "@candidate": "n"}, {"$": "Thailand", "@weight": "b", "@candidate": "n"}, {"$": "Viral Load", "@weight": "b", "@candidate": "n"}, {"$": "Young Adult", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": null, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Epidemiology", "@code": "2713", "@abbrev": "MEDI"}, {"@_fa": "true", "$": "Immunology", "@code": "2403", "@abbrev": "IMMU"}, {"@_fa": "true", "$": "Infectious Diseases", "@code": "2725", "@abbrev": "MEDI"}, {"@_fa": "true", "$": "Virology", "@code": "2406", "@abbrev": "IMMU"}]}, "authors": {"author": [{"ce:given-name": "Torsak", "preferred-name": {"ce:given-name": "Torsak", "ce:initials": "T.", "ce:surname": "Bunupuradah", "ce:indexed-name": "Bunupuradah T."}, "@seq": "1", "ce:initials": "T.", "@_fa": "true", "affiliation": {"@id": "60031780", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780"}, "ce:degrees": "MD", "ce:surname": "Bunupuradah", "@auid": "15836773400", "author-url": "https://api.elsevier.com/content/author/author_id/15836773400", "ce:indexed-name": "Bunupuradah T."}, {"ce:given-name": "Sasisopin", "preferred-name": {"ce:given-name": "Sasisopin", "ce:initials": "S.", "ce:surname": "Kiertiburanakul", "ce:indexed-name": "Kiertiburanakul S."}, "@seq": "2", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60015887", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887"}, "ce:degrees": "MD", "ce:surname": "Kiertiburanakul", "@auid": "6506539792", "author-url": "https://api.elsevier.com/content/author/author_id/6506539792", "ce:indexed-name": "Kiertiburanakul S."}, {"ce:given-name": "Anchalee", "preferred-name": {"ce:given-name": "Anchalee", "ce:initials": "A.", "ce:surname": "Avihingsanon", "ce:indexed-name": "Avihingsanon A."}, "@seq": "3", "ce:initials": "A.", "@_fa": "true", "affiliation": {"@id": "60031780", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780"}, "ce:degrees": "MD", "ce:surname": "Avihingsanon", "@auid": "57196347321", "author-url": "https://api.elsevier.com/content/author/author_id/57196347321", "ce:indexed-name": "Avihingsanon A."}, {"ce:given-name": "Ploenchan", "preferred-name": {"ce:given-name": "Ploenchan", "ce:initials": "P.", "ce:surname": "Chetchotisakd", "ce:indexed-name": "Chetchotisakd P."}, "@seq": "4", "ce:initials": "P.", "@_fa": "true", "affiliation": {"@id": "60017165", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017165"}, "ce:degrees": "MD", "ce:surname": "Chetchotisakd", "@auid": "56992885200", "author-url": "https://api.elsevier.com/content/author/author_id/56992885200", "ce:indexed-name": "Chetchotisakd P."}, {"ce:given-name": "Malee", "preferred-name": {"ce:given-name": "Malee", "ce:initials": "M.", "ce:surname": "Techapornroong", "ce:indexed-name": "Techapornroong M."}, "@seq": "5", "ce:initials": "M.", "@_fa": "true", "affiliation": {"@id": "60028340", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028340"}, "ce:degrees": "MD", "ce:surname": "Techapornroong", "@auid": "22037090700", "author-url": "https://api.elsevier.com/content/author/author_id/22037090700", "ce:indexed-name": "Techapornroong M."}, {"ce:given-name": "Niramon", "preferred-name": {"ce:given-name": "Niramon", "ce:initials": "N.", "ce:surname": "Leerattanapetch", "ce:indexed-name": "Leerattanapetch N."}, "@seq": "6", "ce:initials": "N.", "@_fa": "true", "affiliation": {"@id": "60012921", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012921"}, "ce:degrees": "MD", "ce:surname": "Leerattanapetch", "@auid": "57189350431", "author-url": "https://api.elsevier.com/content/author/author_id/57189350431", "ce:indexed-name": "Leerattanapetch N."}, {"ce:given-name": "Pacharee", "preferred-name": {"ce:given-name": "Pacharee", "ce:initials": "P.", "ce:surname": "Kantipong", "ce:indexed-name": "Kantipong P."}, "@seq": "7", "ce:initials": "P.", "@_fa": "true", "affiliation": {"@id": "102066915", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/102066915"}, "ce:degrees": "MD", "ce:surname": "Kantipong", "@auid": "6603580797", "author-url": "https://api.elsevier.com/content/author/author_id/6603580797", "ce:indexed-name": "Kantipong P."}, {"ce:given-name": "Chureeratana", "preferred-name": {"ce:given-name": "Chureeratana", "ce:initials": "C.", "ce:surname": "Bowonwatanuwong", "ce:indexed-name": "Bowonwatanuwong C."}, "@seq": "8", "ce:initials": "C.", "@_fa": "true", "affiliation": {"@id": "60029201", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029201"}, "ce:degrees": "MD", "ce:surname": "Bowonwatanuwong", "@auid": "19833745200", "author-url": "https://api.elsevier.com/content/author/author_id/19833745200", "ce:indexed-name": "Bowonwatanuwong C."}, {"ce:given-name": "Sukit", "preferred-name": {"ce:given-name": "Sukit", "ce:initials": "S.", "ce:surname": "Banchongkit", "ce:indexed-name": "Banchongkit S."}, "@seq": "9", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "101867798", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101867798"}, "ce:degrees": "MD", "ce:surname": "Banchongkit", "@auid": "54934454300", "author-url": "https://api.elsevier.com/content/author/author_id/54934454300", "ce:indexed-name": "Banchongkit S."}, {"ce:given-name": "Virat", "preferred-name": {"ce:given-name": "Virat", "ce:initials": "V.", "ce:surname": "Klinbuayaem", "ce:indexed-name": "Klinbuayaem V."}, "@seq": "10", "ce:initials": "V.", "@_fa": "true", "affiliation": {"@id": "107077094", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/107077094"}, "ce:degrees": "MD", "ce:surname": "Klinbuayaem", "@auid": "26636470600", "author-url": "https://api.elsevier.com/content/author/author_id/26636470600", "ce:indexed-name": "Klinbuayaem V."}, {"ce:given-name": "Sripetcharat", "preferred-name": {"ce:given-name": "Sripetcharat", "ce:initials": "S.", "ce:surname": "Mekviwattanawong", "ce:indexed-name": "Mekviwattanawong S."}, "@seq": "11", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "100840713", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100840713"}, "ce:degrees": "MD", "ce:surname": "Mekviwattanawong", "@auid": "53870491900", "author-url": "https://api.elsevier.com/content/author/author_id/53870491900", "ce:indexed-name": "Mekviwattanawong S."}, {"ce:given-name": "Sireethorn", "preferred-name": {"ce:given-name": "Sireethorn", "ce:initials": "S.", "ce:surname": "Nimitvilai", "ce:indexed-name": "Nimitvilai S."}, "@seq": "12", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "123656911", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/123656911"}, "ce:degrees": "MD", "ce:surname": "Nimitvilai", "@auid": "57212277075", "author-url": "https://api.elsevier.com/content/author/author_id/57212277075", "ce:indexed-name": "Nimitvilai S."}, {"ce:given-name": "Supunnee", "preferred-name": {"ce:given-name": "Supunnee", "ce:initials": "S.", "ce:surname": "Jirajariyavej", "ce:indexed-name": "Jirajariyavej S."}, "@seq": "13", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60014909", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014909"}, "ce:degrees": "MD", "ce:surname": "Jirajariyavej", "@auid": "24764685100", "author-url": "https://api.elsevier.com/content/author/author_id/24764685100", "ce:indexed-name": "Jirajariyavej S."}, {"ce:given-name": "Wisit", "preferred-name": {"ce:given-name": "Wisit", "ce:initials": "W.", "ce:surname": "Prasithsirikul", "ce:indexed-name": "Prasithsirikul W."}, "@seq": "14", "ce:initials": "W.", "@_fa": "true", "affiliation": {"@id": "60021173", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021173"}, "ce:degrees": "MD", "ce:surname": "Prasithsirikul", "@auid": "14032276000", "author-url": "https://api.elsevier.com/content/author/author_id/14032276000", "ce:indexed-name": "Prasithsirikul W."}, {"ce:given-name": "Warangkana", "preferred-name": {"ce:given-name": "Warangkana", "ce:initials": "W.", "ce:surname": "Munsakul", "ce:indexed-name": "Munsakul W."}, "@seq": "15", "ce:initials": "W.", "@_fa": "true", "affiliation": {"@id": "60033133", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60033133"}, "ce:degrees": "MD", "ce:surname": "Munsakul", "@auid": "35308921700", "author-url": "https://api.elsevier.com/content/author/author_id/35308921700", "ce:indexed-name": "Munsakul W."}, {"ce:given-name": "Sorakij", "preferred-name": {"ce:given-name": "Sorakij", "ce:initials": "S.", "ce:surname": "Bhakeecheep", "ce:indexed-name": "Bhakeecheep S."}, "@seq": "16", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60092132", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60092132"}, "ce:degrees": "MD", "ce:surname": "Bhakeecheep", "@auid": "13614152900", "author-url": "https://api.elsevier.com/content/author/author_id/13614152900", "ce:indexed-name": "Bhakeecheep S."}, {"ce:given-name": "Suchada", "preferred-name": {"ce:given-name": "Suchada", "ce:initials": "S.", "ce:surname": "Chaivooth", "ce:indexed-name": "Chaivooth S."}, "@seq": "17", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60092132", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60092132"}, "ce:degrees": "MD", "ce:surname": "Chaivooth", "@auid": "57189031115", "author-url": "https://api.elsevier.com/content/author/author_id/57189031115", "ce:indexed-name": "Chaivooth S."}, {"ce:given-name": "Praphan", "preferred-name": {"ce:given-name": "Praphan", "ce:initials": "P.", "ce:surname": "Phanuphak", "ce:indexed-name": "Phanuphak P."}, "@seq": "18", "ce:initials": "P.", "@_fa": "true", "affiliation": {"@id": "60031780", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780"}, "ce:degrees": "MD", "ce:surname": "Phanuphak", "@auid": "7004982661", "author-url": "https://api.elsevier.com/content/author/author_id/7004982661", "ce:indexed-name": "Phanuphak P."}, {"ce:given-name": "David A", "preferred-name": {"ce:given-name": "David A.", "ce:initials": "D.A.", "ce:surname": "Cooper", "ce:indexed-name": "Cooper D.A."}, "@seq": "19", "ce:initials": "D.A.", "@_fa": "true", "affiliation": {"@id": "60026655", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026655"}, "ce:degrees": "DSc", "ce:surname": "Cooper", "@auid": "36078697200", "author-url": "https://api.elsevier.com/content/author/author_id/36078697200", "ce:indexed-name": "Cooper D.A."}, {"ce:given-name": "Tanakorn", "preferred-name": {"ce:given-name": "Tanakorn", "ce:initials": "T.", "ce:surname": "Apornpong", "ce:indexed-name": "Apornpong T."}, "@seq": "20", "ce:initials": "T.", "@_fa": "true", "affiliation": {"@id": "60031780", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780"}, "ce:degrees": "MSc", "ce:surname": "Apornpong", "@auid": "36597857000", "author-url": "https://api.elsevier.com/content/author/author_id/36597857000", "ce:indexed-name": "Apornpong T."}, {"ce:given-name": "Stephen J", "preferred-name": {"ce:given-name": "Stephen J.", "ce:initials": "S.J.", "ce:surname": "Kerr", "ce:indexed-name": "Kerr S.J."}, "@seq": "21", "ce:initials": "S.J.", "@_fa": "true", "affiliation": [{"@id": "60031780", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780"}, {"@id": "60026655", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026655"}, {"@id": "60002483", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002483"}], "ce:degrees": "PhD", "ce:surname": "Kerr", "@auid": "7102711578", "author-url": "https://api.elsevier.com/content/author/author_id/7102711578", "ce:indexed-name": "Kerr S.J."}, {"ce:given-name": "Sean", "preferred-name": {"ce:given-name": "Sean", "ce:initials": "S.", "ce:surname": "Emery", "ce:indexed-name": "Emery S."}, "@seq": "22", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60026655", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026655"}, "ce:degrees": "PhD", "ce:surname": "Emery", "@auid": "57188785246", "author-url": "https://api.elsevier.com/content/author/author_id/57188785246", "ce:indexed-name": "Emery S."}, {"ce:given-name": "Kiat", "preferred-name": {"ce:given-name": "Kiat", "ce:initials": "K.", "ce:surname": "Ruxrungtham", "ce:indexed-name": "Ruxrungtham K."}, "@seq": "23", "ce:initials": "K.", "@_fa": "true", "affiliation": [{"@id": "60031780", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780"}, {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}], "ce:degrees": "MD", "ce:surname": "Ruxrungtham", "@auid": "7004208798", "author-url": "https://api.elsevier.com/content/author/author_id/7004208798", "ce:indexed-name": "Ruxrungtham K."}]}}}